[A comparison of efficacy and tolerance of furamag and norbactin in the treatment of acute cystitis in females].
Urologiia
; (6): 11-7, 2009.
Article
en Ru
| MEDLINE
| ID: mdl-20175279
ABSTRACT
Efficacy and tolerance of furamag and norbactin were compared in a prospective controlled trial with participation of 82 females aged 18-60 years with acute uncomplicated cystitis. All the women were divided into two groups. Group 1 (n=42) received norbactin (norfloxacin) in a dose 400 mg twice a day for 7 days. Group 2 (n=40) was given furamag in a dose 50 mg 3 times a day for 10 days. The results were evaluated 2 weeks after the treatment. The comparison of the treatment results showed that a new nitrofuranic drug furamag has significantly higher clinical and bacteriological efficacy acute cystitis was cured in 95% patients, eradication of the infective agent occurred in 96.4% patients, tolerance was good in 97.5% patients. Sensitivity of the agents causing acute cystitis to nitrofurans reached 98.2% while to norbactin--only 86%.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Norfloxacino
/
Cistitis
/
Antibacterianos
/
Nitrofuranos
Tipo de estudio:
Clinical_trials
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
Ru
Revista:
Urologiia
Asunto de la revista:
UROLOGIA
Año:
2009
Tipo del documento:
Article